Skip to main content
. 2021 Nov 5;12:735554. doi: 10.3389/fendo.2021.735554

Figure 1.

Figure 1

Proportion of general and specific symptomatology (A) and requirement for specific therapeutic management (B) in COVID-19 patients attending pediatric endocrine centers. MS, metabolic syndrome; CNS, central nervous system; DKA, Diabetic ketoacidosis; ICU, Intensive Care Unit; IL-6, Interleukin-6.